Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
23
2022
A Closer Look at China’s New E-Cigarette Regulations Keller and Heckman LLP
Aug
23
2022
New Study on Heavy Metal Levels in Baby Foods Keller and Heckman LLP
Aug
22
2022
Drug Pricing Reform Finally Becomes Law: What the Inflation Reduction Act Means for Pharma ArentFox Schiff LLP
Aug
22
2022
Recent FDA Warning Letter to Amazon.com Suggests the Agency Is Getting Tired of the Whack-a-Mole Game Mintz
Aug
22
2022
Class Action Alleges Feta Cheese Made in USA Misleadingly Suggests European Origin Keller and Heckman LLP
Aug
19
2022
Food and Chemicals Unpacked: Got Milk? An Inside Look at the Infant Formula Shortage [PODCAST] Keller and Heckman LLP
Aug
19
2022
Alabama Medical Cannabis Commission Approves Rules for Cannabis Operators Bradley Arant Boult Cummings LLP
Aug
19
2022
Court Of Appeal Agrees $280 Pizza Oven Is Not A "Thing Of Value" Allen Matkins Leck Gamble Mallory & Natsis LLP
Aug
19
2022
All Things Chemical: Is There A New Chemical Bias? — A Conversation with Richard E. Engler, Ph.D. [PODCAST] Bergeson & Campbell, P.C.
Aug
18
2022
Draft Drugs, Medical Devices and Cosmetics Bill, 2022: Dawn of a New Era? Nishith Desai Associates
Aug
18
2022
FDA Publishes Pesticide Residue Report for FY 2020 Keller and Heckman LLP
Aug
18
2022
Giving Pennsylvanians a Second Chance: Ethics Investigation Spurs PALCB Changes in Limited-Release Lotteries Norris McLaughlin P.A.
Aug
18
2022
MLB To Allow CBD Sponsorships ArentFox Schiff LLP
Aug
17
2022
Wine Labelling: A New EU Regulation Is Coming Into Force in 2023 K&L Gates
Aug
17
2022
Hearing Aids: More Accessible to Consumers After FDA Issues Final Rule
Aug
17
2022
GT Legal Food Talk Episode 17: Setting the Table: Greenberg Traurig's Riley Lagesen and the Restaurant Industry [PODCAST] Greenberg Traurig, LLP
Aug
17
2022
CERCLA PFAS Designation Major Step Forward CMBG3 Law
Aug
17
2022
Whole Foods Rice Pilaf Slack Fill Lawsuit Dismissed Keller and Heckman LLP
Aug
16
2022
NASEM Recommends That EPA Conduct Ecological Risk Assessment of UV Filters Found in Sunscreen, Including Titanium Oxide and Zinc Oxide Bergeson & Campbell, P.C.
Aug
16
2022
Recent Federal Developments - August 2022 Bergeson & Campbell, P.C.
Aug
16
2022
On the Attack: FDA Pursues Online Retail Fulfillment House
Aug
16
2022
Lawsuit Alleges Plant Butter Deceptively Labeled Keller and Heckman LLP
Aug
15
2022
Release of Paper-Based Version of FDA’s Agricultural Water Assessment Builder Keller and Heckman LLP
Aug
13
2022
2022 Liquor Liability Laws – A 50-State Survey Wilson Elser Moskowitz Edelman & Dicker LLP
Aug
12
2022
Despite Decriminalization Of Adult Recreational Use Of Marijuana, Court Finds Its Use Is Not Lawful Allen Matkins Leck Gamble Mallory & Natsis LLP
Aug
11
2022
FDA Publishes Industry Guidance on Shell Egg Rule Keller and Heckman LLP
Aug
11
2022
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Aug
11
2022
In the Weeds? Humira “Patent Thicket” Isn’t an Antitrust Violation McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins